Lack of effects by σ ligands on neuropeptide Y-induced G-protein activation in rat hippocampus and cerebellum

Brain Research

Volumn 901, Issue 1-2, 2001, Pages 208-218

  Hong, Weimin ^a   Werling, Linda ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

35S GTP S autoradiography; Cerebellum; GTPase; Hippocampus; Neuropeptide Y; Sigma receptor

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; HALOPERIDOL; N [2 (3,4 DICHLOROPHENYL)ETHYL] N METHYL 2 (1 PYRROLIDINYL)CYCLOHEXYLAMINE; NEUROPEPTIDE Y; SIGMA RECEPTOR LIGAND;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CEREBELLUM; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HIPPOCAMPUS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION;

ANALGESICS; ANIMALS; CELL MEMBRANE; CEREBELLUM; CYCLOHEXYLAMINES; DOPAMINE ANTAGONISTS; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HALOPERIDOL; HIPPOCAMPUS; LIGANDS; MALE; NEUROPEPTIDE Y; PYRROLIDINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, SIGMA; SUBCELLULAR FRACTIONS; SULFUR RADIOISOTOPES;

EID: 0035906525     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02348-4     Document Type: Article

References (35)

1. 1-like receptor
2. 3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands
3. 1 receptor antagonists
4. Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in the mouse hippocampal formation
5. Catecholamine-stimulated GTPase activity in turkey erythrocyte membranes
6. 2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells
7. 1 receptor antagonist BIBP 3226
8. 2 receptor radioligands
9. 1-binding site
10. ++ mobilization by N-methyl-d-aspartate in primary culture of rat frontal cortical neurons
11. 1-receptor: Novel regulatory mechanism affecting intracellular calcium concentration
12. 1 receptor is not directly coupled to G proteins
13. Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons
14. + and GTP in inhibitory regulation of adenylate cyclase
15. 125I-neuropeptide Y imply receptor heterogeneity
16. 2 receptors in a human neuroblastoma cell line
17. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog
18. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors
19. Inverse agonism: Pharmacological curiosity or potential therapeutic strategy?
20. Neuropeptide Y potentiates the N-methyl-d-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor
21. Neuropeptide Y potentiates selectively the N-methyl-d-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor
22. B receptor agonists in rat cerebral cortical membranes through distinct modes of action
23. A simplification of the protein assay method of Lowry et al. which is more generally applicable
24. 35S] binding at activated NPY receptor subtypes in adult rat brain
25. 2+ entry
26. Multiple receptors for neuropeptide Y in the hippocampus: Putative roles in seizures and cognition
27. Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites
28. mu-Opioid receptor-stimulated guanosine-5′-O-(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy
29. 2 receptors for neuropeptide Y are coupled to three intracellular signal transduction pathways in a human neuroblastoma cell line
30. 35S]thio]-triphosphate binding
31. Neuropeptide Y and peptide YY do not bind to brain sigma and phencyclidine binding sites
32. Neuropeptide Y - A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide
33. Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals
34. Neuropeptide Y-related peptides and their receptors - Are the receptors potential therapeutic drug targets?
35. 2 receptor subtypes in human and rat brain